214 related articles for article (PubMed ID: 11760829)
1. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture.
Chesnut CH; Rosen CJ;
J Bone Miner Res; 2001 Dec; 16(12):2163-72. PubMed ID: 11760829
[TBL] [Abstract][Full Text] [Related]
2. Is bone mineral density predictive of fracture risk reduction?
Cefalu CA
Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
[TBL] [Abstract][Full Text] [Related]
3. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
Felsenberg D; Boonen S
Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
[TBL] [Abstract][Full Text] [Related]
4. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
5. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
Garnero P; Delmas PD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
[TBL] [Abstract][Full Text] [Related]
6. Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses.
Delmas PD; Li Z; Cooper C
J Bone Miner Res; 2004 Feb; 19(2):330-7. PubMed ID: 14969404
[TBL] [Abstract][Full Text] [Related]
7. Important determinants of bone strength: beyond bone mineral density.
Friedman AW
J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
Miller RG
Geriatrics; 2006 Jan; 61(1):24-30. PubMed ID: 16405361
[TBL] [Abstract][Full Text] [Related]
9. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.
Stone KL; Seeley DG; Lui LY; Cauley JA; Ensrud K; Browner WS; Nevitt MC; Cummings SR;
J Bone Miner Res; 2003 Nov; 18(11):1947-54. PubMed ID: 14606506
[TBL] [Abstract][Full Text] [Related]
10. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
11. Emerging concepts in osteoporosis and bone strength.
Rubin CD
Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
[TBL] [Abstract][Full Text] [Related]
12. Identification of osteopenic women at high risk of fracture: the OFELY study.
Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in understanding the genetic susceptibility to osteoporosis.
Zmuda JM; Cauley JA; Ferrell RE
Genet Epidemiol; 1999; 16(4):356-67. PubMed ID: 10207717
[TBL] [Abstract][Full Text] [Related]
14. American College of Sports Medicine position stand. Osteoporosis and exercise.
Med Sci Sports Exerc; 1995 Apr; 27(4):i-vii. PubMed ID: 7791573
[TBL] [Abstract][Full Text] [Related]
15. Who will benefit from antiresorptive treatment (bisphosphonates)?
Papapoulos SE
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190
[TBL] [Abstract][Full Text] [Related]
16. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
17. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
Jakob F; Marín F; Martín-Mola E; Torgerson D; Fardellone P; Adami S; Thalassinos NC; Sykes D; Melo-Gomes J; Chinn C; Nicholson T; Cooper C
QJM; 2006 Aug; 99(8):531-43. PubMed ID: 16861718
[TBL] [Abstract][Full Text] [Related]
18. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
Seeman E
Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
[TBL] [Abstract][Full Text] [Related]
19. [Increase in bone mineral density and its effect on fracture risk].
Sone T
Clin Calcium; 2005 Apr; 15(4):625-9. PubMed ID: 15802775
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis workup: evaluating bone loss and risk of fractures.
Murray C; O'Brien K
Geriatrics; 1995 Sep; 50(9):41-6, 53; quiz 54-5. PubMed ID: 7672617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
